VICTORIA SINIBALDI: Open Payments
NPI 1093744369 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,615 in 16 payments from 9 companies in 2025. Trend: 2023 $1,849 · 2024 $4,702 · 2025 $1,615
Food & beverage: $1,615
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $599 |
| Exelixis Inc. | 3 | $319 |
| Daiichi Sankyo Inc. | 2 | $207 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| JAZZ PHARMACEUTICALS INC. | 1 | $69 |
| PFIZER INC. | 1 | $25 |
| TerSera Therapeutics LLC | 1 | $24 |
Products named: Nubeqa, CABOMETYX, NERLYNX, ENHERTU, OPDIVO, ZEPZELCA, PADCEV, Zoladex.
Industry payments across MD — which companies pay providers there.
